Buch, Englisch, Band 17, 579 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 11253 g
Buch, Englisch, Band 17, 579 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 11253 g
Reihe: Advances in Biochemistry in Health and Disease
ISBN: 978-3-319-60323-0
Verlag: Springer International Publishing
In recent years, several articles have focused on advancing our knowledge on the profound effect of hyperglycemia and insulin resistance on building up vascular wall inflammation leading to endothelial dysfunction in patients with diabetes mellitus Other reports have elaborated on the various disorders, hyperglycemia can lead to, their therapies, adverse effects and complications. There are also studies that highlight the role of factors that induce vascular wall alterations in hyperglycemia.
In this book, we attempt to discuss vascular disease progression in diabetes with a unique approach. We attempt to provide a complete perspective of the pathophysiology of vascular complications and then dissect each of the factors that play a key role in accelerating vascular wall alterations in diabetes. Each of these factors has been adversely implicated in the initiation and progression of disease to a large extent. In this collection for the first time all these factors would be described under a common canopy. Further, the text would emphasize on pathogenesis of micro vascular complications of diabetes, such as retinopathy, neuropathy and nephropathy. Pharmacological therapies for treating vascular dysfunction in diabetes mellitus would also be reviewed. This compendium hopefully would be an invaluable replacement to scores of literature on diabetic vascular disease and would be of great interest to clinicians, academicians, medical students and researchers.
The book will be divided into seven sections, each emphasizing a common incentive to development of vascular disease in diabetes. Section I deals with pathophysiology of diabetic vascular disease, beginning with an update on the global burden of diabetes mellitus and its vascular complications. The pathophysiology and pathogenesis of diabetes associated macrovasculopathy, how hyperglycemia functions as an atherogenic factor, effects of hyperglycemia on smooth muscle accumulation in vascular lesions and genetic susceptibility for increased risk of vascular disease in diabetes will be discussed in the following chapters of this section.
The next section (Section II) surveys the process of endothelial dysfunction under hyperglycaemia and hyperinsulinemia and their effects on angiogenesis, vascular remodeling and wound healing. A chapter is also dedicated to the endothelial progenitor cell population and its dysfunction during development of vascular complications in diabetes.
Section III will highlight the molecular mechanisms underlying endothelial dysfunction, various pathways such as nitric oxide synthase pathway, oxidative stress pathway, renin – angiotensin system and increased vascular superoxide production in the initiation and progression of vascular disease in diabetes. This section also covers role of endothelin, monocyte derived cytokines, peroxynitrate and adipokines in macrovascular complications of diabetes.
Metabolic factors such as advanced glycation end products, atherogenic dyslipoproteinaemia, and homocysteine will be reviewed in Section IV, whereas an overview of the hemostatic factors such as platelet dysfunction, hyperglycaemia induced thrombin formation and aberrant clot lysis will be dwelled upon in Section V.Section VI includes chapters on microvascular complications of diabetes which encompasses long term complications of diabetes affecting small blood vessels of the eye, kidneys and nervous system. The pathogenesis and mechanisms of these complications would be detailed here.
The final section (Section VII) of the book will consider mechanism of action of drugs for treating endothelial dysfunction in diabetes mellitus which would elaborate on lipid regulating therapies such as statins, as well as other therapies such as ACE inhibitors, Angiotensin II receptors, insulin, metformin and their effects on enhancing vascular function in diabetes.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
Section 1 Introduction.- The Global Burden Of Diabetes And Its Vascular Complications.- SECTION 2 Pathogenesis.- Genetic Basis For Increased Risk For Vascular Diseases In Diabetes.- Vascular Remodelling In Diabetes Mellitus.- Pathogenesis Of The Plaque Vulnerability In Diabetes Mellitus.- Endothelial Dysfunction In Diabetes.- Smooth Muscle Cells In Diabetes Mellitus.- Monocytes Factors In Pathogenesis Of Vascular Lesions In Diabetes.- Endothelial Progenitor Cell Dysfunction In The Pathogenesis Of Vascular Complications Of Diabetes.- Pathogenetic mechanisms in diabetic retinopathy: from molecules to cells to tissues.- Perspectives on the vascular pathogenesis of diabetic neuropathy.- SECTION 3 Molecular mechanisms.- The Renin - Angiotensin System And Diabetes.- Adipokines And Vascular Disease In Diabetes.- G-Proteins In Vascular Complications Of Diabetes.- Histone Deacetylases In Vascular Pathophysiology: Regulation By Vasoactive Peptides And Growth Factors.- Role of non-coding RNAs in vascular complications of diabetes mellitus.- SECTION 4 Hemostatic Factors.- Diabetes As A Prothrombotic State.- Mechanisms Of Hypercoagulation And Aberrant Clot Lyses In Type 2 Diabetes.- Platelet Dysfunction In Type-2 Diabetes Mellitus.- SECTION 5 Metabolic Factors.- Advanced Glycation End Products In Diabetic Complications.- Atherogenicdyslipoproteinemia In Type 2 Diabetes Mellitus.- Vascular Remodeling: Homocysteine And Diabetes.- SECTION 6 Pharmacological Therapies.- Mechanisms Of Action Of Drugs For Treating Endothelial Dysfunction In Diabetes Mellitus.- Beneficial Effects Of Inorganic Nitrate/Nitrite On Vascular Function And Blood Pressure In Diabetes.- Myeloperoxidase (MPO): Do We Need Inhibitors?.
